Carrie Johnson

My name is Carrie Johnson and I am a fourth-year PhD candidate at the Sander’s Brown Center on Aging in Dr. Paul Murphy’s lab, and a second-year recipient of the TRIAD T32 fellowship. Our research focuses mainly on Alzheimer’s Disease (AD) and the molecular pathways that are affected by AD pathology.

From left to right: Dr. Rachel Wilson, Lisa Williams, Renee Gallagher, and LeAnn Barber

Burnout is a problem in any profession, but it is rampant in health care. This national problem has been evident recently as the COVID-19 pandemic pushed many learners, practitioners, faculty, and staff to the limit.

A report on Alzheimer's disease.  Click here to view the video featuring Sanders-Brown faculty.

Hubbard Lab members.

The University of Kentucky has been awarded a prestigious Centers of Biomedical Research Excellence (COBRE) grant to study central nervous system metabolism from the National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health (NIH). The $10.6 million, five-year grant will fund UK’s Center of Research in Central Nervous System Metabolism (CNS-Met). 

The back of a t-shirt that reads: Sanders Brown Center on Aging, We Back Pat

This story was originally published by WKYT here.

Sanders-Brown Center on Aging Clinic building at UK HealthCare's Turfland Campus

This Labor Day, WKYT-TV, is highlighting the world-class work going on at the University of Kentucky’s Sanders-Brown Center on Aging. The Lexington-based CBS affiliate will air a 30-minute special on their second station, The CW, at 6:30 p.m. Monday, Sept. 4. 

Zhihui Zhu, PhD, (left) and Erhard Bieberich, PhD, (right) working at a lab computer

A team of researchers at the University of Kentucky has found that a drug used to treat multiple sclerosis (MS) is potentially effective as a therapy for Alzheimer’s disease.

Rohan Desai in the lab

My name is Rohan Desai, and I am a third-year undergraduate student currently working in the lab Maj-Linda Selenica, PhD, to study the effects of TDP-43 proteinopathy in the multi-etiology of the Alzheimer’s Disease (AD), LATE, and FTD spectrum.

Dr. Anika Hartz

Anika Hartz, PhD, was recently promoted to professor in the UK College of Medicine Department of Pharmacology and Nutritional Sciences. The secret to her success is rooted in her love for science and pursuing groundbreaking discoveries.

Abigail Latimer, Laurie McLouth, Elizabeth Rhodus, and Jim Ballard

Asked how she copes with the emotional side of her role in palliative care, Abigail Latimer, PhD, MSW, LCSW, puts it simply. “I want to be there for people on some of their hardest days.”

Stock photo of woman on computer

The University of Kentucky College of Medicine is excited to announce that faculty, staff, learners, and trainees will have free access to a leading online resource for medical Spanish proficiency.

CanopyLearn, a Spanish language training program for health care professionals, will be available to the UK College of Medicine community starting Aug. 1.

Panhavuth Phe with microscope

My name is Panhavuth Phe and I am a recent neuroscience graduate from the UK College of Arts and Sciences and am also a graduate of the Lewis Honors College.  I have received departmental honors from the UK College of Medicine Neuroscience Department and was recognized as the  “Most Valuable Committee Member” for the 2022 NeuroWeek that was organized by the three UK undergraduate neur

Photo of patient at Sanders-Brown

LEXINGTON, Ky. (WKYT) - WKYT is continuing its in-depth look at the work of the Sanders-Brown Center on Aging. The organization, affiliated with the University of Kentucky, employs 125 people. One of them is an RN, and she’s gaining a reputation with her research participants.

SBCoA director Linda J. Van Eldik, Ph.D., on March 14, 2019. Mark Cornelison

A recent study from the lab of the University of Kentucky’s Sanders-Brown Center on Aging Director Linda Van Eldik, Ph.D., has been published in PLOS ONE. The work centers around the idea that various anti-inflammatory drugs could be effective treatments for Alzheimer’s disease (AD). This study focused on a protein known as p38.

Photo from event

(LEX 18) — College students can find themselves on all kinds of interesting trips, but one group from Western Kentucky University is on an all-out adventure.

"We ride, usually, about 70, 75 miles a day and then from there, we get off the bike, get something to eat, go to sleep, wake up and do it all over again," said Trey Englehardt.

Headshot of Dr. Na'Tasha Evans

Na’Tasha Evans, PhD, MEd, is a researcher, published author, champion for female empowerment, and our new vice dean for diversity, equity, and inclusion at the University of Kentucky College of Medicine. Learn more about her goals, her past work, and more in the following Q&A.

Q: What inspired you to pursue a career in research? 

Photo of Sanders-Brown Clinic

On July 6, 2023, the U.S. Food and Drug Administration (FDA) granted full approval to lecanemab, marketed as Leqembi, for the treatment of Alzheimer’s disease.

Jim Jackson of Morehead participates in a clinical trial at the University of Kentucky
 𝑇ℎ𝑒 𝑎𝑟𝑡𝑖𝑐𝑙𝑒 𝑏𝑒𝑙𝑜𝑤 𝑤𝑎𝑠 𝑓𝑖𝑟𝑠𝑡 𝑝𝑢𝑏𝑙𝑖𝑠ℎ𝑒𝑑 𝑏𝑦 𝑇ℎ𝑒 𝐾𝑒𝑛𝑡𝑢𝑐𝑘𝑦 𝐿𝑎𝑛𝑡𝑒𝑟𝑛 𝑐𝑜𝑢𝑟𝑡𝑒𝑠𝑦 𝑜𝑓 𝑡ℎ𝑒 𝑟𝑒𝑝𝑜𝑟𝑡𝑖𝑛𝑔 𝑜𝑓 𝑆𝑎𝑟𝑎ℎ 𝐿𝑎𝑑𝑑.


Faculty at the promotion ceremony

Congratulations to the following basic science and clinical faculty at the University of Kentucky College of Medicine! These individuals were honored with promotions and tenure in fiscal year 2023.

Names are organized alphabetically by department.


Sarah Jean Hall, MD, PhD
Associate Professor

Close up of a brain scan

A researcher at the University of Kentucky will work to better understand the connection between posttraumatic stress disorder (PTSD) and dementia.